Press Releases

Sep 8, 2020

Biopharma leaders unite to stand with science

- Nine CEOs sign historic pledge to continue to make the safety and well-being of vaccinated individuals the top priority in development of the first COVID-19 vaccines
Sep 3, 2020

Late-breaking Libtayo® (cemiplimab) pivotal data in advanced non-small cell lung cancer and basal cell carcinoma to be presented at ESMO
Aug 17, 2020

Sanofi to acquire Principia Biopharma

* Further strengthens core R&D areas of autoimmune and allergic diseases
Jul 31, 2020

Sanofi and GSK selected for Operation Warp Speed to supply United States government with 100 million doses of COVID-19 vaccine

- Promising vaccine candidate selected by U.S. government’s Operation Warp Speed
Jul 30, 2020

Nirsevimab reduced respiratory syncytial virus infections requiring medical care in healthy premature infants in Phase 2b trial

- Nirsevimab reduced respiratory syncytial virus (RSV) lower respiratory tract infections by 70 percent and related hospitalizations by 78 percent1

Show per page